XML 19 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Operating Expenses    
Research and development $ 6,554,194 $ 5,482,531
Sales and marketing 1,429,150 1,075,376
General and administrative 5,174,215 4,940,398
Total operating expenses 13,157,559 11,498,305
Operating loss (13,157,559) (11,498,305)
Other Expenses    
Gain on extinguishment of debt 0 (308,600)
Other income (expense) (21,533) (41,545)
Total other expenses (21,533) 267,055
Loss from operations before income taxes (13,179,092) (11,231,250)
Provision for income taxes 0 0
Net Loss (13,179,092) (11,231,250)
Deemed dividend 0 (121,071)
Net Loss attributable to common stockholders $ (13,179,092) $ (11,352,321)
Net loss per share - basic and diluted $ (4.56) $ (5.55)
Weighted average common shares - basic and diluted 2,891,292 2,046,135